Chronic infection in the aetiology of atherosclerosis - Focus on Chlamydia pneumoniae

Atherosclerosis

Volumn 143, Issue 1, 1999, Pages 1-6

  Gupta, Sandeep ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aetiology of atherosclerosis; Chlamydia pneumoniae; Chronic infection

Indexed keywords

ANTIBIOTIC AGENT; MACROLIDE; PLACEBO;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 0032991466     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00317-7     Document Type: Article

References (73)

1. Nieminen M.S., Mattila K., Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J. 14:1993;12-16.
2. Farmer J.A., Gotto A.M. Jr. Dyslipidaemia and other risk factors for coronary artery disease. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. 5th edn:1997;1126-1160 Saunders, Philadelphia.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
4. Azar R.R., Waters D.D. The inflammatory eitology of unstable angina. Am Heart J. 132:1996;1101-1106.
5. Hansson G.K. Immune mechanisms in atherosclerosis. Atherosclerosis. 9:1989;567-568.
6. Steinberg D., Parthasarathy S., Carew T. et al. Modifications of low-density lipoprotein that increases its atherogenicity. New Engl J Med. 320:1989;915-924.
7. Fabricant C.G., Fabricant J., Litrenta M.M., Minick C.R. Virus-induced atherosclerosis. J Exp Med. 148:1978;335-340.
8. Fabricant C.G., Fabricant J., Minick C.R., Litrenta M.M. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 42:1983;2467-2469.
9. Havlik R.J., Blackwelder W.C., Kaslow R. et al. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Heart Study. Arteriosclerosis. 9:1989;877-880.
10. Melnick J.L., Petrie B.L., Dreesman G.R. et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 2:1983;644-647.
11. Zhou Y.F., Leon M.B., Waclawiw M.A. et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. New Engl J Med. 335:1996;624-630.
12. McDonald K., Rector T.S., Braunlin E.A. et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol. 64:1989;359-362.
13. Kol A., Sperti G., Shani J. et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation. 91:1995;1910-1913.
14. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
15. Mendall M.A., Goggin P.M., Molineaux N. et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 71:1994;437-439.
16. Martin-de-Argila C., Boixeda D., Canton R. et al. High seroprevalence of Helicobacter pylori infection in coronary heart disease (Letter). Lancet. 346:1995;310.
17. Murray L.J., Bamford K.B., O'Reilly D.P. et al. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J. 74:1995;497-501.
18. Whincup P.H., Mendall M.A., Perry I.J. et al. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart. 75:1996;568-572.
19. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br. Med. J. 315:1997;1199-1201.
20. Patel P., Mendall M.A., Carrington D. et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. 311:1995;711-714.
21. Parente F., Maconi G., Imbesi V. et al. Helicobacter pylori infection and coagulation in healthy people. Br. Med. J. 314:1997;1318-1319.
22. Blasi F., Denti F., Erba M. et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 34:1996;2766-2769.
23. Mattila K.J., Nieminen M.S., Valtonen V.V. et al. Association between dental health and acute myocardial infarction. Br. Med. J. 298:1989;779-782.
24. Jousilahti P., Vartianinen E., Tacomilekhot T. et al. Symptoms of chronic bronchitis and risk of coronary disease. Lancet. 348:1996;567-572.
25. Saikku P., Leinonen M., Mattila K. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
26. Wang S.P., Grayston J.T. Microimmunofluorescence serology in Chlamydia trachomatis. de la Maza L.M. The 1983 International Symposium on Medical Virology. 1984;87-118 Elsevier, New York.
27. Gupta S., Camm A.J. Chlamydia pneumoniae and coronary heart disease: coincidence, association or causation? Br. Med. J. 314:1997;1778-1779.
28. Shor A., Kuo C.C., Patton D.L. Detection of Chlamydia pneuomoniae in coronary arterial fatty streaks and atheromatous plaques. South Afr Med J. 82:1992;158-161.
29. Kuo C.C., Shor A., Campbell L.A. et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 167:1993;841-849.
30. Kuo C.C., Gown A.M., Benditt E.P. et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 13:1993;1501-1504.
31. Campbell L.A., O'Brien E.R., Cappuccio A.L. et al. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 172:1995;585-588.
32. Davidson M., Kuo C.C., Middaugh J.P. et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:1998;628-633.
33. Tuazon C.U., Varghese P.J., Gaydos C.A. et al. Demonstration of Chlamydia pneumoniae in coronary atheroma specimens from young patients with normal cholesterol from the Southern part of India (Abstract). Clin Infect Dis. 21:1995;728.
34. Kuo C.C., Grayston J.T., Campbell L.A. et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA. 92:1995;6911-69114.
35. Grayston J.T., Kuo C.C., Coulson A.S. et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92:1995;3397-3400.
36. Ong G., Thomas B.J., Mansfield A.O. et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol. 49:1996;101-106.
37. Ong G, Thomas BJ, Mansfield AO et al. Chlamydia pneumoniae in vascular tissue. In: Stary A, editor, Proc. of 3rd Meet. of the European Society of Chlamydia Research. Vienna, 11-14 September 1996, p. 222.
38. Muhlestein J.B., Hammond E.H., Carlquist J.F. et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 27:1996;1555-1561.
39. Weiss SM, Roblin PM, Gaydos CA et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957-962.
40. Ramirez J.A. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Intern Med. 125:1996;979-982.
41. Jackson L.A., Campbell L.A., Kuo C.-C. et al. Isolation of Chlamydia pneumoniae (TWAR) from a carotid atherosclerotic plaque specimen. J Infect Dis. 176:1997;292-295.
42. Juvonen J., Juvonen T., Laurila A. et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortoc aneurysms. J Vasc Surg. 25:1997;499-505.
43. Gaydos C.A., Summersgill J.T., Sahney N.N. et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immunol. 64:1996;1614-1620.
44. Kaukoranta -Tolvanen S.S., Teppo A.M., Laitinen K. et al. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microbiol Pathog. 21:1996;215-221.
45. Mendall M.A., Carrington D., Strachan D.P. et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 30:1995;121-128.
46. Leatham E.W., Bath P.M., Tooze J.A. et al. Increased monocyte tissue factor expression in coronary disease. Br Heart J. 73:1995;10-13.
47. Juvonen J., Laurila A., Juvonen T. et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 29:1991;1054-1059.
48. Moazed T.C., Kuo C.C., Patton D.L. et al. Experimental rabbit models of Chlamydia pneumoniae infection. Am J Path. 148:1996;667-678.
49. Fong I.W., Chiu B., Viira E. et al. Rabbit models for Chlamydia pneumoniae infection. J Clin Microbiol. 35:1997;48-52.
50. Laitinen K., Laurila A., Pyhälä L. et al. Chlamydia pneumoniae induces inflammatory changes in the aortas of rabbits. Infect Immun. 65:1997;4832-4835.
51. Gupta S., Leatham E.W., Carrington D. et al. The effect of azithromycin in post myocardial infarction patients with elevated Chlamydia pneumoniae antibody titres (Abstract). J Am Coll Cardiol. 755:1997;209.
52. Gupta S., Leatham E.W., Carrington D. et al. Elevated Chlamydia penumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
53. Gurfinkel E., Bozovich G., Darcoca A., Beck E., Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 350:1997;404-407.
54. Black P.N. Anti-inflammatory effects of macrolide antibiotics. Eur Resp J. 10:1997;971-972.
55. Kalayoglu M.V., Byrne G.I. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 177:1998;725-729.
56. Hahn D.L., Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arterioscler Thromb. 12:1992;255-260.
57. Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;2910-2913.
58. Cook P.J., Lip G.Y., Davies P., Beevers D.G., Wise R. Chlamydia pneumoniae antibodies in severe essential hypertension. Hypertension. 31:1998;589-594.
59. Toss H., Gnarpe J., Gnarpe A. et al. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J. 19:1998;570-577.
60. Dahlén G.H., Boman J., Birgander L.S., Lindholm B. Lipoprotein(a), IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease. Atherosclerosis. 114:1995;165-174.
61. Maass M., Bartels C., Engel P.M. et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 31:1998;827-832.
62. Boman J., Söderberg S., Forsberg J. et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis. 178:1998;274-277.
63. Wong Y-K, Dawkins K, Ward ME. Detection of Chlamydia pneumoniae DNA circulating in the blood of patients attending for cardiac angiography: preliminary clinical and seriological correlates. In: Stephens RS, Byrne GI, Christiansen G et al., editors. Chlamydial Infections. San Francisco, CA: International Chlamydial Symposium, 1998:227-30.
64. Bengston A., Karlsson T., Hjalmarson Å., Herlitz J. Complications prior to revascularisation among patients waiting for coronary artery bypass grafting and percutaneous transluminal coronary angioplasty. Eur Heart J. 17:1996;1846-18451.
65. Anderson JL, Muhlestein JB. Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia. ACADEMIC study. Presented at 47th Scientific Session of the American College of Cardiology, Atlanta, USA, 1998.
66. Moxon E.R. Microbes, molecules and man. The Mitchell Lecture 1992. J R Coll Physicians Lond. 27:1993;169-174.
67. Gupta S., Kaski J.C., Camm A.J. Antibiotic therapy in coronary heart disease: hype versus hope. Br J Cardiol. 5:1998;65-66.
68. Wise R., Hart T., Cars O. et al. Antimicrobial resistance. Br. Med. J. 317:1998;609-610.
69. Marshall B.J. Helicobacter pylori in peptic ulcer: have Koch's postulates been fulfilled? Ann Med. 27:1995;565-568.
70. Sanderson J.D., Moss M.T., Tizard M.L., Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissues. Gut. 33:1992;890-896.
71. Silman A.J. Is rheumatoid arthritis an infectious disease? Br. Med. J. 303:1991;200-201.
72. Saboor S.A., Johnson N., McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet. 339:1992;1012-1015.
73. Gupta S. Chlamydia pneumoniae, monocyte activation and antimicrobial therapy in coronary heart disease. M.D. Thesis, University of London, 1999.